Results 161 to 170 of about 58,013 (257)

Unlocking binding properties of single-domain antibodies targeting the polymeric immunoglobulin receptor to enhance mucosal enrichment of IgG against respiratory syncytial virus. [PDF]

open access: yesFront Immunol
Liu J   +18 more
europepmc   +1 more source

Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential. [PDF]

open access: yesJ Biol Chem
Golonka RM   +10 more
europepmc   +1 more source

Affinity- and Format-Dependent Pharmacokinetics of 89Zr-Labeled Albumin-Binding VHH Constructs. [PDF]

open access: yesPharmaceuticals (Basel)
Leekens S   +7 more
europepmc   +1 more source

A High-Affinity Nanobody Selectively Recognizing KPC-2/KPC-3: Biochemical and Structural Insights. [PDF]

open access: yesBiomolecules
Hamdi E   +10 more
europepmc   +1 more source

Systematic perturbation of cultures of K. phaffii by carbon co-feeding show gene signatures associated with production of recombinant proteins. [PDF]

open access: yesMicrob Cell Fact
Acharya R   +8 more
europepmc   +1 more source

Llama VHH as immunotherapeutics in Alzheimer's disease

open access: yes, 2013
Alzheimer's Disease (AD) is the most common form of dementia among elderly in the Western world. AD is a devastating neurodegenerative disease where patients starting with episodic memory problems end up completely bedridden and care dependent. At present there is no real therapy stopping or reversing AD progression.
openaire   +2 more sources

Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers. [PDF]

open access: yesRes Pract Thromb Haemost
Alessi MC   +14 more
europepmc   +1 more source

More tools to uncover cancer cells. [PDF]

open access: yesMol Ther Oncol
Pignataro MF, Santos J.
europepmc   +1 more source

Home - About - Disclaimer - Privacy